5.10Open1.80Pre Close14 Volume32 Open Interest53.00Strike Price7.14KTurnover205.99%IV-2.24%PremiumNov 15, 2024Expiry Date6.15Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9594Delta0.0270Gamma7.56Leverage Ratio-0.3179Theta-0.0005Rho-7.25Eff Leverage0.0014Vega
CRISPR Therapeutics Stock Discussion
-TSLA
-PLTR
-SQ
were sold out in the last 10 days.
But, the institution also bought back some of
+COIN
+Amazon
+ILMN
+Meta
at lower price.
But on Nov 6, they bought back 1 Billion worth of TSLA at +/- 281 $ and 468 Million worth of PLTR stock at +/- 55$ back in their portfolio...
(Probably FOMO for PLTR or ...
Most of Wallstreet and retail investors don't understand Crispr and most see it as a very risky stock to invest in but once it begins rolling out its cures and making obscene amounts of cash..Along with license agreements to other companies Crispr Theraputics share price will rise significantly. ...
$ONEOK Inc (OKE.US)$ : “I think Oneok is terrific. I would indeed buy more.”
$DexCom (DXCM.US)$ : “Dexcom had a real bad miss. They still really haven’t fully explained why that is...I’d stay away from De...
No comment yet